Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Dec;55(1):2226909.
doi: 10.1080/07853890.2023.2226909.

Investigation of ocular involvement in patients with Fabry disease

Affiliations

Investigation of ocular involvement in patients with Fabry disease

Yuan Wu et al. Ann Med. 2023 Dec.

Abstract

Purpose: To investigate ocular abnormalities in Fabry disease (FD).

Methods: Forty-five patients with FD diagnosed by genetic analysis were enrolled in a single medical centre. The following ocular examinations were performed: slit-lamp examination, ophthalmic fundus imaging, in vivo confocal microscopy (IVCM) and optical coherence tomography (OCT). The prevalences of typical abnormalities in the cornea, conjunctiva and retina were recorded; their differences between hemizygote and heterozygote were compared.

Results: In this study, the prevalence of corneal verticillata was 97.8% (44/45). Corneal examination with IVCM demonstrated hyper-reflective intracellular inclusions located within basal epithelial cells. Conjunctival vessel malformations were observed in 64.4% (29/45) of patients, and retinal vessel tortuosity was observed in 62.2% (28/45) of patients. OCT revealed many strong hyper-reflective foci (HRF) in the inner retinal layer (in 66.7% [30/45] of patients); these foci may represent retinal vascular plexi. The prevalences of conjunctival vessel malformation, retinal vessel tortuosity and HRF were higher in hemizygote than in heterozygote.

Conclusions: Corneal verticillata, HRF on OCT, conjunctival vessel malformation and retinal vessel tortuosity exhibit high prevalence in patients with FD. These ocular manifestations are characteristic and easily accessible; thus, they should be considered diagnostic criteria for FD.

Keywords: Fabry disease; corneal verticillata; optical coherence tomography; retinal vessel tortuosity.

Plain language summary

The main ocular features of the patients with FD are corneal verticillata, HRF on OCT, conjunctival vessel malformation and retinal vessel tortuosity.These ocular manifestations should be considered as the diagnostic criteria of FD.

PubMed Disclaimer

Conflict of interest statement

No potential conflict of interest was reported by the author(s).

Figures

Figure 1.
Figure 1.
Cornea verticillate (A), spoke-like appearance of lens (B) and conjunctival vessel malformation (C, D) of Fabry patient.
Figure 2.
Figure 2.
Scans of cornea in in vivo confocal microscopy.
Figure 3.
Figure 3.
Venular tortuosity in retina (A, B), strong HRF and weak HRF in OCT scans (C, D), OCT scans of an old central retinal artery occlusion of Fabry patient (E) and her normal contralateral eye (F).

Similar articles

Cited by

References

    1. Chan B, Adam DN.. A review of Fabry disease. Skin Therapy Lett. 2018;23:1–7. - PubMed
    1. Mehta A, Ricci R, Widmer U, et al. . Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry outcome survey. Eur J Clin Invest. 2004;34(3):236–242. doi: 10.1111/j.1365-2362.2004.01309.x. - DOI - PubMed
    1. Linhart A, Kampmann C, Zamorano JL, et al. . Cardiac manifestations of Anderson-Fabry disease: results from the international Fabry outcome survey. Eur Heart J. 2007;28(10):1228–1235. doi: 10.1093/eurheartj/ehm153. - DOI - PubMed
    1. Mehta A, Ginsberg L.. Natural history of the cerebrovascular complications of Fabry disease. Acta Paediatr Int J Paediatr Suppl. 2005;94(0):24–27. doi: 10.1080/08035320510028076. - DOI - PubMed
    1. Sodi A, Ioannidis AS, Mehta A, et al. . Ocular manifestations of Fabry’s disease: data from the Fabry outcome survey. Br J Ophthalmol. 2007;91(2):210–214. doi: 10.1136/bjo.2006.100602. - DOI - PMC - PubMed

Publication types